Private Wealth Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Private Wealth Asset Management's RPRX Position: Q3 2026 in Review
Private Wealth Asset Management sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 906 shares — an estimated $50.8K sold.
Private Wealth Asset Management first reported a position in RPRX in Q1 2025 and held it in 6 quarters. The position peaked at $50.8K in Q2 2026. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Private Wealth Asset Management reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
- Private Wealth Asset Management sold 906 Royalty Pharma shares in Q3 2026, an estimated $50.8K.
- Private Wealth Asset Management first reported a position in Royalty Pharma in Q1 2025 and held it in 6 quarters.
- Private Wealth Asset Management's Royalty Pharma position peaked at $50.8K in Q2 2026.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Private Wealth Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.